Headlines

ITT Educational Services And 4 Other Stocks Have Very High Payout Ratio

(VIANEWS) – AbbVie (ABBV), ITT Educational Services (ESI), Blackrock Enhanced Equity Dividend Trust (BDJ) are the highest payout ratio stocks on this list.

We have gathered information about stocks with the highest payout ratio at the moment. The payout ratio in itself isn’t a promise of good investment but it’s an indicator of whether dividends are being paid and how the company chooses to distribute them.

When investigating a potential investment, the dividend payout ratio is a good statistic to know so here are a few stocks with an above 30% percent payout ratio.

1. AbbVie (ABBV)

160.27% Payout Ratio

AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals worldwide. The company offers Humira, a therapy administered as an injection for autoimmune, intestinal Behçet's diseases, and pyoderma gangrenosum; Skyrizi to treat moderate to severe plaque psoriasis, psoriatic disease, and Crohn's disease; Rinvoq, a JAK inhibitor to treat rheumatoid and psoriatic arthritis, ankylosing spondylitis, atopic dermatitis, axial spondyloarthropathy, and ulcerative colitis; Imbruvica for the treatment of adult patients with blood cancers; and Venclexta/Venclyxto to treat hematological malignancies. It also provides facial injectables, plastics and regenerative medicine, body contouring, and skincare products; Vraylar for depressive disorder; Duopa and Duodopa to treat advanced Parkinson's disease; and Ubrelvy for the acute treatment of migraine with or without aura in adults; Qulipta for episodic migraine. In addition, the company offers Lumigan/Ganfort and Alphagan/Combigan for the reduction of elevated intraocular pressure(IOP) in patients with open angle glaucoma (OAG) or ocular hypertension; Restasis, a calcineurin inhibitor immunosuppressant indicated to increase tear production; and eye care products. Further, it provides Mavyret/Maviret to treat chronic hepatitis C virus (HCV) genotype 1-6 infection and HCV genotype 1 infection; Creon, a pancreatic enzyme therapy; Lupron to treat advanced prostate cancer, endometriosis and central precocious puberty, and patients with anemia caused by uterine fibroids; Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation; and Synthroid for hypothyroidism. It has collaborations with Calico Life Sciences LLC; REGENXBIO Inc.; I-Mab Biopharma; Genmab A/S; Janssen Biotech, Inc.; Genentech, Inc.; California Institute for Biomedical Research (Calibr), and BigHat Biosciences, Inc. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois.

Earnings Per Share

As for profitability, AbbVie has a trailing twelve months EPS of $3.65.

PE Ratio

AbbVie has a trailing twelve months price to earnings ratio of 42.15. Meaning, the purchaser of the share is investing $42.15 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 46.32%.

Earnings Before Interest, Taxes, Depreciation, and Amortization

AbbVie’s EBITDA is 5.79.

Dividend Yield

As maintained by Morningstar, Inc., the next dividend payment is on Jan 11, 2024, the estimated forward annual dividend rate is 6.2 and the estimated forward annual dividend yield is 4.02%.

Volume

Today’s last reported volume for AbbVie is 1643490 which is 68.7% below its average volume of 5252290.

Moving Average

AbbVie’s value is above its 50-day moving average of $144.17 and higher than its 200-day moving average of $146.96.

Previous days news about AbbVie (ABBV)

  • According to Zacks on Friday, 15 December, "In the last five trading sessions, AbbVie rose the most (4.8%), while Pfizer declined the most (8.6%)."
  • AbbVie (abbv) declines more than market: some information for investors. According to Zacks on Friday, 15 December, "Any recent changes to analyst estimates for AbbVie should also be noted by investors. ", "The investment community will be closely monitoring the performance of AbbVie in its forthcoming earnings report. "

2. ITT Educational Services (ESI)

152.38% Payout Ratio

Element Solutions Inc operates as a specialty chemicals company in the United States, China, and internationally. The company operates in two segments, Electronics, and Industrial & Specialty. The Electronics segment researches, formulates, and sells specialty chemicals and materials for various types of electronics hardware products. This segment also supplies solder technologies, fluxes, cleaners, and other attachment materials for the electronics assembly industry; proprietary liquid chemical processes to manufacture printed circuit boards; and advanced copper interconnects, die attachment, wafer bump processes, and photomask technologies for integrated circuit fabrication and semiconductor packaging. It primarily serves mobile communications, computers, automobiles, and aerospace equipment industries. The Industrial & Specialty segment provides industrial solutions, which include chemical systems that protect and decorate metal and plastic surfaces; consumable chemicals that enable printing image transfer on flexible packaging materials; and chemistries used in water-based hydraulic control fluids for offshore energy production applications. It serves aerospace, automotive, construction, consumer electronics, consumer packaged goods, and oil and gas production end markets. The company was formerly known as Platform Specialty Products Corporation and changed its name to Element Solutions Inc in January 2019. Element Solutions Inc was founded in 1785 and is headquartered in Fort Lauderdale, Florida.

Earnings Per Share

As for profitability, ITT Educational Services has a trailing twelve months EPS of $0.21.

PE Ratio

ITT Educational Services has a trailing twelve months price to earnings ratio of 101.19. Meaning, the purchaser of the share is investing $101.19 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 2.24%.

Dividend Yield

According to Morningstar, Inc., the next dividend payment is on Nov 29, 2023, the estimated forward annual dividend rate is 0.32 and the estimated forward annual dividend yield is 1.51%.

Revenue Growth

Year-on-year quarterly revenue growth declined by 3.1%, now sitting on 2.33B for the twelve trailing months.

Earnings Before Interest, Taxes, Depreciation, and Amortization

ITT Educational Services’s EBITDA is 2.93.

3. Blackrock Enhanced Equity Dividend Trust (BDJ)

98.33% Payout Ratio

BlackRock Enhanced Equity Dividend Trust is a closed-ended equity mutual fund launched by BlackRock, Inc. The fund is managed by BlackRock Advisors, LLC. It invests in the public equity markets of the United States. The fund seeks to invest in stocks of companies operating across diversified sectors. It primarily invests in dividend paying stocks of companies across all market capitalizations. The fund also invests through derivatives, with an emphasis on option writing. It benchmarks the performance of its portfolio against the Russell 1000 Value Index. The fund was formerly known as BlackRock Enhanced Dividend Achievers TM Trust. BlackRock Enhanced Equity Dividend Trust was formed on August 31, 2005 and is domiciled in the United States.

Earnings Per Share

As for profitability, Blackrock Enhanced Equity Dividend Trust has a trailing twelve months EPS of $0.85.

PE Ratio

Blackrock Enhanced Equity Dividend Trust has a trailing twelve months price to earnings ratio of 9.18. Meaning, the purchaser of the share is investing $9.18 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 9.49%.

Volume

Today’s last reported volume for Blackrock Enhanced Equity Dividend Trust is 811928 which is 37.38% above its average volume of 591004.

Revenue Growth

Year-on-year quarterly revenue growth grew by 1.2%, now sitting on 45.17M for the twelve trailing months.

Dividend Yield

As stated by Morningstar, Inc., the next dividend payment is on Dec 13, 2023, the estimated forward annual dividend rate is 0.67 and the estimated forward annual dividend yield is 8.65%.

4. Royce Value Trust (RVT)

90.4% Payout Ratio

Royce Value Trust Inc. is a close ended equity mutual fund launched and managed by Royce & Associates, LLC. It invests in the public equity markets of the United States. The fund spreads its investments across diversified sectors. It invests in value oriented stocks of small cap and micro cap companies. The fund benchmarks the performance of its portfolio against the Russell 2000 Index. Royce Value Trust Inc. was formed on July 1, 1986 and is domiciled in the United States.

Earnings Per Share

As for profitability, Royce Value Trust has a trailing twelve months EPS of $1.25.

PE Ratio

Royce Value Trust has a trailing twelve months price to earnings ratio of 10.98. Meaning, the purchaser of the share is investing $10.98 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 14.68%.

Volume

Today’s last reported volume for Royce Value Trust is 357100 which is 35.15% above its average volume of 264206.

Dividend Yield

As stated by Morningstar, Inc., the next dividend payment is on Dec 7, 2023, the estimated forward annual dividend rate is 1.07 and the estimated forward annual dividend yield is 7.79%.

5. Chesapeake Utilities Corporation (CPK)

45.61% Payout Ratio

Chesapeake Utilities Corporation operates as an energy delivery company. The Regulated Energy segment engages in the natural gas distribution operations in central and southern Delaware, Maryland's eastern shore, and Florida; regulated natural gas transmission in the Delmarva Peninsula and Florida; and regulated electric distribution in northeast and northwest Florida. The Unregulated Energy segment engages in the propane operations in the Mid-Atlantic region and Florida; unregulated natural gas transmission/supply operation in central and eastern Ohio; generation of electricity and steam; and provision of compressed natural gas, liquefied natural gas, and renewable natural gas transportation and pipeline solutions primarily to utilities and pipelines in the eastern United States. This segment also provides other unregulated energy services, such as energy-related merchandise sales; heating, ventilation, and air conditioning services; and plumbing and electrical services. The company was founded in 1859 and is headquartered in Dover, Delaware.

Earnings Per Share

As for profitability, Chesapeake Utilities Corporation has a trailing twelve months EPS of $4.93.

PE Ratio

Chesapeake Utilities Corporation has a trailing twelve months price to earnings ratio of 20.11. Meaning, the purchaser of the share is investing $20.11 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 10.47%.

Moving Average

Chesapeake Utilities Corporation’s value is higher than its 50-day moving average of $93.42 and way below its 200-day moving average of $114.76.

Revenue Growth

Year-on-year quarterly revenue growth grew by 0.4%, now sitting on 672.57M for the twelve trailing months.

Volume

Today’s last reported volume for Chesapeake Utilities Corporation is 228318 which is 18.46% above its average volume of 192732.

1. 1 (1)

1% Payout Ratio

1

Earnings Per Share

As for profitability, 1 has a trailing twelve months EPS of $1.

PE Ratio

1 has a trailing twelve months price to earnings ratio of 1. Meaning, the purchaser of the share is investing $1 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 1%.

Dividend Yield

As stated by Morningstar, Inc., the next dividend payment is on Jan 1, 1970, the estimated forward annual dividend rate is 1 and the estimated forward annual dividend yield is 1%.

Sales Growth

1’s sales growth is 1% for the present quarter and 1% for the next.

Earnings Before Interest, Taxes, Depreciation, and Amortization

1’s EBITDA is 1.

Volatility

1’s last week, last month’s, and last quarter’s current intraday variation average was 1.00%, 1.00%, and 1.00%.

1’s highest amplitude of average volatility was 1.00% (last week), 1.00% (last month), and 1.00% (last quarter).

Leave a Reply

Your email address will not be published. Required fields are marked *